Viewing Study NCT03830905


Ignite Creation Date: 2025-12-25 @ 3:29 AM
Ignite Modification Date: 2026-02-20 @ 12:33 PM
Study NCT ID: NCT03830905
Status: COMPLETED
Last Update Posted: 2020-11-16
First Post: 2019-01-30
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess Efficacy and Safety of XC221 200 mg in the Treatment of Influenza or Other ARVI
Sponsor: PHARMENTERPRISES LLC
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Influenza View
None Acute Respiratory Viral Infections View
Keywords: